Reporting from the frontiers of health and medicine
208 followers 70 articles/week
Opinion: Readers respond to a plea for rare disease progress, vaccine-related injury, and more

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received...

Sat Jun 15, 2024 14:28
Novo Nordisk CEO agrees to Bernie Sanders’ demand to testify on Ozempic, Wegovy prices

WASHINGTON — Novo Nordisk CEO Lars Fruergaard Jørgensen will testify before the Senate after Sen. Bernie Sanders threatened to subpoena the company over its pricing of the popular diabetes drug Ozempic and the obesity drug Wegovy, the Senate health committee announced Friday. The agreement is a finale to a farcical public back-and-forth over apparent...

Sat Jun 15, 2024 01:05
STAT+: Colorado board decides a pricey Novartis medicine is unaffordable

A blockbuster arthritis drug from Novartis may face a limit on what Colorado health plans pay for the medicine after a state board determined the injectable treatment is “unaffordable” for patients. The Colorado Prescription Drug Affordability Board voted Friday to grant the designation to Cosentyx, which is used to treat conditions such as plaque...

Sat Jun 15, 2024 00:03
Opinion: NIH needs reform and restructuring, key Republican committee chairs say

While the best parts of biomedical innovation are represented by ringing the bell at a cancer hospital after the final round of chemotherapy, the worst are reminiscent of Frankenstein’s monster. As investigators continue to gain insight into the early days of Covid-19, the origins of the pandemic may be still up for debate. In addition, congressional...

Fri Jun 14, 2024 19:58
STAT+: Up and down the ladder: The latest comings and goings

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person...

Fri Jun 14, 2024 18:28
STAT+: Pharmalittle: We’re reading about abortion pill access, employer coverage of GLP-1 drugs and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still in progress, but we plan to look in on our Pharmalot ancestor, and enjoy the sound of music here, there and everywhere. This may include what has become our traditional...

Fri Jun 14, 2024 16:57

Build your own newsfeed

Ready to give it a go?
Start a 14-day trial, no credit card required.

Create account